# BK Treatment Study

> **NCT01034176** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 43 (actual)

## Conditions studied

- BK Viremia

## Interventions

- **DRUG:** levofloxacin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01034176
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-06
- **Final completion:** 2012-10
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034176, "BK Treatment Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01034176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*